Binding characteristics of selective serotonin reuptake inhibitors with relation to emission tomography studies
- 14 May 2001
- Vol. 41 (3) , 203-211
- https://doi.org/10.1002/syn.1076
Abstract
When developing ligands for emission tomography studies, one of the major obstacles lies in the selection of ligand candidates. A previously unattended factor such as the influence of temperature on candidate ligand affinity is likely to play a role. By use of rat brain homogenates, the binding characteristics of [3H]‐(S)‐citalopram and [3H]‐(+)‐McN5652 and the receptor‐ligand interaction at the serotonin transporter of 17 selective serotonin reuptake inhibitors were compared at 21°C and 37°C, respectively. Ligand logP values were also calculated. The ratios for Ki at 37°C vs. 21°C varied between 0.2 and 2.2 for the selective serotonin reuptake inhibitors considered in this study, with most of the ligands displaying an inverse relationship between Ki and temperature. Ten of the 17 selective serotonin reuptake inhibitors were found to have pKi values statistically significantly different at 21°C compared to 37°C (P < 0.05). The logP values ranged between 3.6 and 4.8, except for DASB, 5‐iodo‐6‐nitroquipazine, and paroxetine where logP was 1.9, 2.2, and 5.0, respectively. Kd was 0.71 nM at 37°C and 0.31 nM at 21°C for [3H]‐(S)‐citalopram. For [3H]‐(+)‐McN5652 Kd was 0.11 nM at 37°C and 0.08 nM at 21°C. The association and dissociation was much faster for [3H]‐(S)‐citalopram as compared to [3H]‐(+)‐McN5652. It is concluded that temperature may affect Kd differently and that in vitro dissociation may help to predict whether a given ligand may be useful in PET studies. LogP values do not per se predict the potential of a given ligand as an emission tomography tracer. Synapse 41:203–211, 2001.Keywords
Funding Information
- 1991 Pharmacy Foundation
- Health Insurance Fund
- The Lundbeck Foundation
- “Centre for Drug Design and Transport,” the Danish Medical Research Council
This publication has 34 references indexed in Scilit:
- Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brainNeuropsychopharmacology, 1996
- A reappraisal of the relative merits of SPET and PET in the quantitation of neuroreceptors: the advantage of a longer half-life!European Journal of Nuclear Medicine and Molecular Imaging, 1996
- Highly potent indanamine serotonin uptake blockers as radiotracers for imaging serotonin uptake sitesNuclear Medicine and Biology, 1994
- [3H]Paroxetine and [3H]citalopram as markers of the human brain 5-HT uptake site: a comparison studyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
- [11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with petLife Sciences, 1993
- Ligands and tracers for PET studies of the 5-HT system—current statusInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1992
- The pharmacological effect of citalopram resides in the (S)-(+)-enantiomerJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- Temperature Dependence of [3H]Ro 15–1788 Binding to Benzodiazepine Receptors in Human Postmortem Brain HomogenatesJournal of Neurochemistry, 1990
- Inhibitory and regulatory binding sites on the rat brain serotonin transporter: molecular weight of the [3H]paroxetine and [3H]citalopram binding proteinsEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973